June 22, 2025 - 07:32

In a recent statement, the Russian President affirmed that Iran possesses the right to develop nuclear technology for peaceful purposes. This declaration underscores Russia's ongoing support for Iran amidst international scrutiny over its nuclear ambitions. The comments were made during a diplomatic engagement where the Russian leader emphasized the importance of respecting Iran's sovereignty in pursuing its nuclear programs.
The remarks come at a time when Iran's nuclear activities have drawn attention from various global powers, who are concerned about the potential for these programs to lead to the development of nuclear weapons. However, the Russian President reiterated that Iran's intentions should be viewed through the lens of peaceful energy development rather than military expansion.
This position reflects Russia's broader strategy of fostering closer ties with Iran, especially in the context of regional stability and energy cooperation. As discussions around nuclear non-proliferation continue, Russia's stance may influence the dynamics of international negotiations regarding Iran's nuclear future.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...